Illumina Reports Strong Finish to Fourth Quarter and Fiscal Year 2013

04-02-2014 Business Wire HealthComments (0)

IlluminaPharmaceutical

Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the fourth quarter and fiscal year 2013. Fourth quarter 2013 results: Revenue of $387 million, a 25% increase compared to $309 million in the fourth quarter of 2012 GAAP net income for the quarter of $81 million, or $0.56 per diluted share, compared to $72 million, or $0.53 per diluted share, for the fourth quarter of 2012 Non-GAAP net income for the quarter of $65 million, or $0.45 per diluted sh

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top